SAN FRANCISCO, Sept. 20, 2023 (GLOBE NEWSWIRE) Olema Pharmaceuticals, Inc. (("Olema" or "Olema Oncology, NASDAQ:OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development and
Olema Pharmaceuticals (OLMA) Announces New Preclinical KAT6 Inhibitor Data streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.